MedPath

A descriptive observational research for the treatment pattern in patients with Lupus Nephritis using Japanese claim database

Not Applicable
Conditions
upus nephritis
Registration Number
JPRN-UMIN000053093
Lead Sponsor
CHUGAI PHARMACEUTICAL CO.,LTD. Nippon Shinyaku Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

Not applicable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of patients on oral GC 5 mg/day or less (prednisolone equivalent) after 540 days from the Index Date
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath